Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use during the high-risk college transition period. Digital tools like Minder are being studied because they can reach large student populations with flexible, scalable support. Results from this trial provide evidence on whether app-based interventions can meaningfully improve mental health and reduce substance use in this vulnerable demographic.
#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This study evaluates a scalable digital intervention designed to address the critical gap in mental health and substance use support during the high-risk university transition period, where traditional in-person services are often insufficient to meet student demand. The randomized controlled trial design provides rigorous evidence on whether app-based interventions can effectively reduce mental health symptoms and substance use behaviors in this population, informing institutional adoption decisions and resource allocation for student mental health programs. Given the accessibility barriers and stigma that limit help-seeking among university students, demonstrating efficacy of a student-codeveloped mobile intervention has direct implications for prevention and early intervention strategies at scale.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 The Minder app study addresses a genuine clinical need, as university students do experience significant mental health and substance use transitions, and digital interventions offer real scalability advantages when in-person care is limited. However, several important caveats warrant careful interpretation: the study design, outcomes measured, control conditions used, and whether cannabis-specific outcomes were assessed remain unclear from the abstract provided, and we cannot determine if results reflect genuine symptom improvement versus engagement bias or placebo effects common in app-based trials. Digital mental health tools work best as adjuncts to, rather than replacements for, clinical assessment and human contact, particularly for students with moderate to severe substance use or psychiatric comorbidity. For clinicians supporting university students, Minder may have value as a scalable screening or psychoeducational resource, but individual patient assessment remains essential before recommending any app-based intervention, especially regarding substance use where motivational interviewing and personalized counseling often yield superior outcomes than algorithms alone.
| |